日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A class II 5-enolpyruvylshikimate-3-phosphate synthase from Pseudomonas P818 confers robust glyphosate tolerance in transgenic plants

来自假单胞菌 P818 的 II 类 5-烯醇式丙酮酰莽草酸-3-磷酸合酶赋予转基因植物强大的草甘膦耐受性。

期刊:aBIOTECH
影响因子:5
doi:10.1016/j.abiote.2026.100023
Su, Yuhao; Cao, Jie; Liu, Yan; Xie, Xiaodong; Zhao, Tianyong; Cao, Gaoyi; Liu, Yunjun
发表日期：2026
文献求助 收藏

From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis.

从多组学特征到治疗候选药物：肝纤维化的计算预测和实验验证。

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph19030495
Qin Yingying, Ma Shuoshuo, Hong Haoyuan, Zhong Deyuan, Liang Yuxin, Su Yuhao, Chen Yahui, Chen Xing, Zhu Yizhun, Huang Xiaolun
发表日期：2026
文献求助 收藏

Integrative multi-omics reveal a CD4⁺ T cell-derived six-gene signature linking the immune-stromal ecosystem to prognosis and immunotherapy selection in pancreatic cancer

整合多组学揭示了CD4⁺ T细胞来源的六基因特征，该特征将免疫基质生态系统与胰腺癌的预后和免疫治疗选择联系起来

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-026-15613-2
Liang, Yuxin; Ma, Shuoshuo; Chen, Xing; Su, Yuhao; Zhong, Deyuan; Yan, Hongtao; Chen, Yahui; Wang, Ming; Leng, Zhengwei; Huang, Xiaolun
肿瘤
T细胞
肿瘤免疫
细胞生物学
T细胞
胰腺癌
CD4
免疫/内分泌
发表日期：2026
文献求助 收藏

Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy

白细胞介素-2与白细胞介素-10比值在接受抗PD-1治疗的肝细胞癌患者中的预后价值

期刊:Technology in Cancer Research & Treatment
影响因子:2.8
doi:10.1177/15330338261421357
Zhong, Deyuan; Liang, Yuxin; Su, Yuhao; Yang, Qinyan; Yan, Hongtao; Huang, Xiaolun; Shang, Jin
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2026
文献求助 收藏

Depression and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational studies

抑郁症与健康结果：观察性研究的系统评价和荟萃分析的伞状综述

期刊:Translational Psychiatry
影响因子:6.2
doi:10.1038/s41398-025-03463-8
Chen, Xiaojuan; Liu, Xiaoning; Li, Fengjuan; He, Haitian; Li, Xinying; Qin, Tianhang; Jiang, Bin; Chen, Yuge; Wang, Yanqi; Su, Yuhao; Wang, Xiaojie; Liang, Lei; Hua, Huiling; Wu, Jun; Ma, Jianping; Hu, Fulan; Qin, Pei
抑郁症
神经科学
发表日期：2025
文献求助 收藏

Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study

术后辅助肝动脉灌注化疗联合乐伐替尼或不联合PD-1抑制剂治疗孤立性大肝癌的疗效和安全性：一项多中心回顾性研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1609352
Liang, Yuxin; Wang, Ming; Zhong, Deyuan; Yan, Hongtao; Su, Yuhao; Chen, Xing; Huang, Xiaolun; Leng, Zhengwei
肿瘤
肝癌
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis

胰腺癌中树突状细胞相关基因特征可区分患者亚型，并提示KCTD14-TNF信号通路参与其中。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1665906
Liang, Yuxin; Gu, Yuheng; Zhang, Zilong; Zhong, Deyuan; Yan, Hongtao; Su, Yuhao; Chen, Yahui; Wang, Fei; Leng, Zhengwei; Huang, Xiaolun
肿瘤
肿瘤免疫
细胞生物学
信号转导
树突状细胞
胰腺癌
树突状细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis

PD-1抑制剂和TKI联合术前TACE治疗超过“7个以上”肝细胞癌：倾向评分匹配分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1657371
Zhong, Deyuan; Liang, Yuxin; Chen, YaHui; Su, Yuhao; Yang, Qinyan; Yan, Hongtao; Huang, Xiaolun; Wang, Ming
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma.

FCGR2A 决定肝细胞癌的预后免疫亚型并驱动肿瘤进展。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1641420
Zhong Deyuan, Liang Yuxin, Yan Hongtao, Chen Xing, Chen YaHui, Ma Shuoshuo, Su Yuhao, Wang Fei, Chen Xinpei, Yang Qinyan, Leng Zhengwei, Wang Ming, Huang Xiaolun
肝癌
细胞生物学
FCGR2A
发表日期：2025
文献求助 收藏

Association between Body Mass Index and Left Ventricular Ejection Fraction in Obese Patients with Atrial Fibrillation Referred for Catheter Ablation

肥胖房颤患者接受导管消融术时，体重指数与左心室射血分数之间的关联

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2025.1712935
Wan, Rong; Su, Yuhao; Huang, Ying
肥胖
代谢
发表日期：2025
文献求助 收藏